Director of Non-GLP Bioanalysis
WuXi
St Paul, Minnesota
Dr. Zhao graduated from the Physics Department of Nankai University with a bachelor’s degree and obtained a Ph.D. in Physics from Georgia State University in the United States. She has worked at Covance (UT, USA) and Stoke Therapeutics, Inc (Boston, MA), with years of experience in GLP bioanalysis and oligonucleotide drug development.
In October 2020, Dr. Zhao joined the DMPK service department of WuXi AppTec, responsible for the construction of the bioanalysis platforms for oligonucleotide. Dr. Zhao has led and participated in over 500 oligo screening and IND application projects and has rich experience in developing bioanalytical strategies for new modalities drug development to support preclinical and clinical studies like oligonucleotide, ADC, peptide, PROTAC etc. Currently, Dr. Zhao is in charge of the discovery bioanalysis team for in vivo screening group (Shanghai) and reporting team in the DMPK service department.
Overcoming the Unique Challenges in Today’s Early Stage Drug Development
Wednesday, October 25, 2023
9:00 AM – 10:00 AM ET